PROQR THRAPEUTICS N V's ticker is and the CUSIP is N71542909. A total of 2 filers reported holding PROQR THRAPEUTICS N V in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $46,980 | -77.3% | 29,000 | -70.1% | 0.00% | -100.0% |
| Q1 2023 | $206,823 | -38.3% | 97,100 | +7.2% | 0.00% | 0.0% |
| Q4 2022 | $335,220 | +33422.0% | 90,600 | +12842.9% | 0.00% | – |
| Q2 2022 | $1,000 | -97.8% | 700 | -98.6% | 0.00% | – |
| Q1 2022 | $45,000 | -6.2% | 49,800 | +730.0% | 0.00% | – |
| Q4 2021 | $48,000 | -95.6% | 6,000 | -95.4% | 0.00% | -100.0% |
| Q3 2021 | $1,083,000 | +103.6% | 129,400 | +63.8% | 0.00% | 0.0% |
| Q2 2021 | $532,000 | -54.2% | 79,000 | -55.0% | 0.00% | -50.0% |
| Q1 2021 | $1,161,000 | +57950.0% | 175,600 | +43800.0% | 0.00% | – |
| Q4 2020 | $2,000 | -75.0% | 400 | -75.0% | 0.00% | – |
| Q3 2020 | $8,000 | -75.0% | 1,600 | -69.8% | 0.00% | – |
| Q2 2020 | $32,000 | +1500.0% | 5,300 | +1666.7% | 0.00% | – |
| Q1 2020 | $2,000 | -90.0% | 300 | -85.0% | 0.00% | – |
| Q4 2019 | $20,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 700 | $1,000 | 0.00% |
| SIMPLEX TRADING, LLC | 30,600 | $23,000 | 0.00% |